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 Introduction
Hepatocyte growth factor (HGF)-regulated tyrosine kinase
substrate (Hrs) is a prominent target for tyrosine
phosphorylation following activation of tyrosine kinase
receptors (Komada and Kitamura, 1995). It was initially shown
to lie downstream of the HGF/scatter factor receptor c-Met, but
activation of other tyrosine kinase receptors and stimulation
with cytokines such as IL-2 and GM-CSF also results in
phosphorylation of Hrs (Asao et al., 1997). EGF-dependent
phosphorylation of Hrs requires coincident localisation of
activated receptor and Hrs at early endosomes, to which Hrs is
targeted by interaction of its FYVE domain with PtdIns3P
(Urbé et al., 2000).
A role for Hrs in receptor sorting was initially proposed by
analogy with its yeast orthologue Vps27. Vps27 belongs to the
class E set of Vps mutants, defective in transport from the
sorting endosome to the vacuole, by virtue of an inability to
generate cargo-laden vesicles that bud from the limiting
membrane into the endosomal lumen (Bankaitis et al., 1986;
Raymond et al., 1992). The Drosophila homologue of Hrs is
required for invagination of endosomal membranes (Lloyd
et al., 2002). Over-expression of mammalian Hrs leads to a
block in lysosomal trafficking of receptors, retaining them in
enlarged early endosomes that also accumulate mannose 6-
phosphate receptor (Urbé et al., 2000).
Receptor sorting to lumenal vesicles frequently requires
receptor ubiquitination (Hicke, 1999; Katzmann et al., 2001;
Reggiori and Pelham, 2001; Urbanowski and Piper, 2001). Hrs
contains a ubiquitin interaction motif (UIM), which was
initially predicted on the basis of a bioinformatic analysis
revealing homology with a 20 amino acid stretch of the S5 sub-
unit of the proteasome that directly interacts with ubiquitin
(Hofmann and Falquet, 2001). The UIM of Hrs is shared with
a number of proteins known to be involved in endocytic
trafficking. These include epsins, eps15 and eps15R that are
believed to regulate receptor internalisation at the plasma
membrane (Shih et al., 2002). A number of groups have now
experimentally verified the ubiquitin binding properties of the
UIM domain, including that of Hrs (Bilodeau et al., 2002;
Bishop et al., 2002; Klapisz et al., 2002; Lloyd et al., 2002;
Polo et al., 2002; Raiborg et al., 2002; Shih et al., 2002). A
recent paper has revealed that the UIM domain does not only
specify non-covalent binding to ubiquitin, but is also necessary
for mono-ubiquitination of the UIM-containing proteins at a
site lying outside the UIM. Eps15, Eps15R, Hrs and epsins 1
and 2 were each shown to be mono-ubiquitinated to varying
degrees following activation of the EGFR (Klapisz et al., 2002;
Polo et al., 2002; van Delft et al., 1997). 
Hrs is concentrated in flat ‘bilayered’ clathrin coats that
decorate the surface of predominantly early endosomes
(Clague, 2002; Raiborg et al., 2002; Sachse et al., 2002). These
coats also provide a site of concentration for receptors destined
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Hepatocyte growth factor regulated tyrosine kinase
substrate (Hrs), a main component of the ‘bilayered’
clathrin coat on sorting endosomes, was originally
identified as a substrate of activated tyrosine kinase
receptors. We have analysed Hrs phosphorylation in
response to epidermal growth factor (EGF) stimulation and
show that the evolutionary conserved tyrosines Y329 and
Y334 provide the principal phosphorylation sites. Hrs is
proposed to concentrate ubiquitinated receptors within
clathrin-coated regions via direct interaction with its UIM
(ubiquitin interaction motif) domain. We show that the
same UIM domain is necessary for EGF-stimulated
tyrosine phosphorylation of Hrs. Over-expression of wild-
type Hrs or a double mutant, Y329/334F, defective in EGF-
dependent phosphorylation, both substantially retard EGF
receptor (EGFR) degradation by inhibiting internal vesicle
formation and thereby preventing EGFR incorporation
into lumenal vesicles of the multivesicular bodies. In
contrast, mutation or deletion of the Hrs-UIM domain
strongly suppresses this effect. In addition the UIM-
deletion and point mutants are also observed on internal
membranes, indicating a failure to dissociate from the
endosomal membrane prior to incorporation of the
receptor complex into lumenal vesicles. Our data suggest a
role for the UIM-domain of Hrs in actively retaining EGFR
at the limiting membrane of endosomes as a prelude to
lumenal vesicle formation.
Key words: Hrs, Endocytosis, Clathrin, Ubiquitin, Phosphorylation
Summary
The UIM domain of Hrs couples receptor sorting to
vesicle formation
Sylvie Urbé1,*, Martin Sachse2,3, Paula E. Row1, Christian Preisinger4, Francis A. Barr4, Ger Strous2,3,
Judith Klumperman2,3 and Michael J. Clague1
1Physiological Laboratory, University of Liverpool, Crown St., Liverpool L69 3BX, UK
2Department of Cell Biology, University Medical Center Utrecht and Institute of Biomembranes, 3584 CX Utrecht, The Netherlands
3Center for Biomedical Genetics, PO Box 80042, 3508 TA Utrecht, The Netherlands
4Department of Cell Biology, Max-Planck-Institute of Biochemistry, Am Klopferspitz, 18a, Martinsried, 82152 Germany
*Author for correspondence (e-mail: urbe@liv.ac.uk)
Accepted 23 June 2003
Journal of Cell Science 116, 4169-4179 © 2003 The Company of Biologists Ltd
doi:10.1242/jcs.00723
Research Article
4170
for lysosomal degradation (EGFR and growth hormone
receptor) but not for the recycling transferrin receptor (Sachse
et al., 2002). It has been proposed that Hrs may act as an
adaptor protein between ubiquitinated receptors and the
clathrin coat (Clague, 2002). Indeed internalized transferrin
can be retained within the early endosome if the cytoplasmic
domain of the transferrin receptor is fused in frame to ubiquitin
(Raiborg et al., 2002). In yeast, the UIM domain of Vps27 was
shown to be required for efficient delivery of cargo to the
lumen of the vacuole (Bilodeau et al., 2002; Shih et al., 2002). 
So far, none of the identified components of the bilayered
clathrin coat was found incorporated into lumenal vesicles,
which often seem to form at the edges of coated areas (Sachse
et al., 2002). This suggests a breaking of the connection
between receptor cargo and the coat prior to vesicle
incorporation, which may involve localised coat disassembly.
Intriguing molecular explanations include competition for
the Hrs UIM domain by other ubiquitinated factors at the
endosome and translocation of phosphorylated Hrs to the
cytosol (Clague, 2002; Sachse et al., 2002; Urbé et al., 2000).
We have identified the major sites of phosphorylation on
Hrs following EGF stimulation and we show that the UIM
domain is required for phosphorylation. Conversely,
phosphorylation is not required for UIM-dependent
ubiquitination. These observations have allowed us to
examine the requirement for Hrs phosphorylation and Hrs-
ubiquitin interaction with respect to its function in the sorting
of EGFR. Together, fluorescence and electron microscopic
studies suggest that the UIM-domain of Hrs plays an
important role in the co-ordination of the sorting of EGFR
from the clathrin-coated limiting endosomal membrane into
the lumenal vesicles as well as in the concomitant
dissociation of Hrs from the receptor complex.
Materials and Methods
Cell culture, plasmids and transfections
HeLa cells were cultured in a 5% CO2 atmosphere in Dulbecco’s
modified Eagle medium supplemented with 10% FBS and 1% non-
essential amino acids. All tissue culture reagents were purchased from
Invitrogen Life Technologies, UK. For overexpression of GFP-tagged
Hrs, the ORF of mouse Hrs was cloned into pEGFP-C (Clontech;
details available on request). The UIM-deletion mutant (amino acids
257-278 deleted) was generated by PCR-based mutagenesis in
pGEMT-Hrs, sequenced and the PmlI-XhoI fragment was subcloned
into pEGFP-Hrs (GFP-ΔUIM). The point mutants GFP-Y329F, GFP-
Y334F, GFP-Y329/334F and GFP-L269/S270A (GFP-LSAA) were
generated by site directed mutagenesis of pGEMT-Hrs by
Quickchange mutagenesis (Stratagene; primers available on request),
sequenced and the PmlI-XhoI fragment subcloned into pEGFP-Hrs.
HeLa cells were transfected according to a standard calcium
phosphate precipitation method or with FuGENE 6 according to the
manufacturer’s instructions (Roche Diagnostics, UK). Typically 30-
50% of cells expressed GFP-Hrs 22 hours post-transfection.
Antibodies and other reagents
Hrs polyclonal antibody generated against a C-terminal peptide has
been described previously (Sachse et al., 2002). The rabbit polyclonal
anti-phospho-Y334-Hrs antibody was generated against the peptide
C-LNRN-Y(Pi)-WEKK. Monoclonal anti-ubiquitin antibody FK2
was purchased from Affiniti, UK. The anti-GFP antibody used in
biochemical experiments was affinity-purified from sheep antiserum
and has previously been described (Barr et al., 2001). Anti-transferrin
receptor antibody was purchased from Roche Diagnostics, UK and
the anti-EGFR antibody was a gift of Harry Mellor, Bristol, UK. The
CI-M6PR antibody was a kind gift from Dr Paul Luzio, Cambridge,
UK (Reaves et al., 1996). The anti-phosphotyrosine monoclonal
antibody, PY20, was obtained from Transduction Laboratories.
Purified mouse EGF was obtained from Dr J. Smith, Liverpool, UK.
Fluorescent secondary antibodies were from Molecular Probes; HRP-
coupled secondary antibodies, Protein A- and Protein G-agarose were
purchased from Sigma. Antibodies used for immunogold labelling
were as follows: Rabbit antiserum against GFP was a kind gift from
Dr David Shima (Cancer Research, United Kingdom). Sheep
antiserum against EGFR was obtained from Invitrogen (Leek, The
Netherlands). Rabbit antiserum against sheep IgG was obtained from
Nordica (Tilburg, The Netherlands). Rabbit antiserum against clathrin
heavy chain was a kind gift from Dr S. Corvera (University of
Massachusetts, MA).
Mass spectrometry
Proteins were extracted from Coomassie-Blue-stained gel slices and
digested with trypsin using a protocol modified from that of
Shevchenko et al. (Shevchenko et al., 1996). Excised gel pieces were
cut into 1 mm cubes and transferred to a 1.5 ml microcentrifuge tube,
then washed in 100 µl volumes of 50 mM NH4HCO3 for 10 minutes,
and 100 µl acetonitrile for 10 minutes. This washing step was repeated
twice. Acetonitrile was then removed by centrifugation in a vacuum
centrifuge for 5 minutes at 40°C. To reduce the protein the gel
particles were swelled in 10 µl of 10 mM DTT in 50 mM NH4HCO3
and incubated for 45 minutes at 56°C. Once cooled to room
temperature excess liquid was removed and replaced immediately
with 10 µl of freshly prepared 55 mM iodoacetamide in 50 mM
NH4HCO3 for 30 minutes at room temperature in the dark. Gel
particles were washed with 100 µl of 50 mM NH4HCO3 followed by
100 µl of acetonitrile for 10 minutes. Acetonitrile was then removed
by centrifugation in a vacuum centrifuge for 5 minutes at 40°C, and
the gel pieces rehydrated in 10 µl of 12.5 ng/µl sequencing-grade
porcine trypsin (Promega) in 50 mM NH4HCO3 on ice. After 15
minutes, 10 µl of 50 mM NH4HCO3 were added and digestion
allowed to proceed at 37°C for 16 hours. The peptide digests were
analysed by peptide mass fingerprinting using a MALDI-TOF
instrument (Reflex III, Bruker) and probability-based database
searching (Perkins et al., 1999).
EGF stimulation and detection of phosphorylated Hrs and
GFP-Hrs
Cells were starved for 16 hours in serum-free medium and then
stimulated with 100 ng/ml EGF. The cells were washed twice with ice
cold PBS and lysed for 20 minutes on ice in lysis buffer (25 mM Tris-
HCl pH 7.5, 100 mM NaCl, 0.5% NP40, 50 mM NaF, supplemented
with mammalian protease inhibitor cocktail and phosphatase inhibitor
cocktail II; Sigma). Where indicated, 10 mM NEM was included in
the lysis buffer. The lysate was pre-cleared by centrifugation and 0.7
to 1 mg of protein at 1 mg/ml was incubated with 5 µl of anti-Hrs or
1.5 µl anti-GFP and Protein A- or Protein G-sepharose respectively.
Immunoprecipitates were washed three times with 25 mM Tris-HCl
pH 7.5, 150 mM NaCl, supplemented with phosphatase inhibitor
cocktail II and then once with 10 mM Tris pH 7.5 before preparation
for SDS-PAGE (8% gels unless indicated otherwise). Following SDS-
PAGE, proteins were either transferred to PVDF or nitrocellulose
membranes (Millipore and Schleicher & Schuell, 0.45 µm) which
were blocked overnight with blocking buffer, 1% BSA/0.1% Tween-
20 in 10 mM Tris, pH 7.5, 100 mM NaCl or with 5% skimmed milk
powder, 0.2% Triton X-100 in 10 mM Tris, pH 7.5, 100 mM NaCl.
Primary and secondary antibody incubations were for 2 and 1 hours
in the respective blocking buffer. Development of western blots was
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by ECL using Pierce Supersignal. Blots were routinely stripped and
reprobed to assess that equal amounts of protein had been
immunoprecipitated in each sample.
Boiling SDS-lysis method
For the detection of ubiquitinated GFP-Hrs, transfected cells were
lysed immediately, without prior washing, in 400 µl boiling lysis
buffer (2% SDS, 1 mM EDTA, 50 mM NaF, supplemented with
phosphatase inhibitor cocktail II and protease inhibitor cocktail,
preheated at 110°C). The lysates were transferred to screw-cap tubes
and incubated for a further 10 minutes at 110°C before being cooled
to room temperature. The lysates were then diluted with 4 volumes of
dilution buffer (2.5% Triton X-100, 12.5 mM Tris pH 7.5, 187.5 mM
NaCl and phosphatase inhbibitor cocktail II and mammalian protease
inhibitor cocktail) to a final concentration of 0.4% SDS, 2% Triton
X-100. The lysates were precleared by centrifugation and subjected
to immunoprecipitation overnight at 4°C with 1.5 µl anti-GFP
antibody and Protein G-agarose. Immunoprecipitates were washed
three times with Triton X-100/SDS wash buffer (2% Triton X-100,
0.4% SDS, 10 mM Tris pH 7.5, 150 mM NaCl) and then once with
10 mM Tris pH 7.5 before preparation for SDS-PAGE.
Preparation of membrane and cytosolic fractions
Cells were homogenised in homogenisation buffer (HB: 10 mM
Hepes, 3 mM imidazole-HCl, pH 7.2, 250 mM sucrose, mammalian
protease inhibitor cocktail) by repeated passage through a 23G needle
at 4°C and then immediately supplemented with 50 mM NaF and
phosphatase inhibitor cocktail II. Membrane/particulate and cytosolic
fractions were prepared from post nuclear supernatants by
ultracentrifugation for 15 minutes at 65,000 rpm in a Beckman TLA
100.2 rotor in an Optima-Max Ultracentrifuge. 
Immunofluorescence
Transfected cells grown on cover slips were washed twice with PBS
and fixed with 3% paraformaldehyde (PFA, TAAB, UK) in PBS.
Residual PFA was quenched with 50 mM NH4Cl/PBS. Cells were
permeabilised with 0.2% Triton X-100/PBS and blocked with 10%
goat serum in PBS. All antibody dilutions were in 5% goat serum and
incubation times were 20-30 minutes at room temperature. Cover slips
were mounted using Moviol and cells were viewed using a BioRad
LaserSharp confocal microscope. Z-sections were taken at 260 nm
steps and analysed with the accompanying software.
Immunogold electron microscopy on cryosections
Cells transfected with GFP-Hrs, GFP-Y329/334F, GFP-ΔUIM, GFP-
LSAA or mocktransfected with FuGENE 6 (Roche Diagnostics) were
starved for 16 hours in serum-free medium and stimulated 22 hours
post-transfection with EGF (100 ng/ml). Cells were then fixed
immediately with 2% paraformaldehyde and 0.2% glutaraldehyde in
0.1 M phosphate buffer pH 7.4 for 2.5 hours at room temperature. The
fixative was removed and free aldehydes were quenched with 50 mM
glycine in PBS. Embedding in 12% gelatin and preparation for
ultrathin cryosectioning and immunogold labeling was done as
described previously (Raposo et al., 1997).
The relative distribution of EGFR label between the limiting
membrane and internal membranes of endosomal vacuoles under
different conditions was determined in the electron microscope on
grids double labeled with rabbit anti-GFP (10 nm gold) and sheep
anti-EGFR (15 nm gold). For each transfection at least 3 times 10 cell
profiles, with a nucleus visible in the plane of the section, were
analyzed. Gold particles representing EGFR within a distance of 20
nm of a membrane were considered as membrane-associated and
assigned to the subdomain of the endosomal vacuole to which they
localized. In parallel, the number of EGFR-positive vacuoles per cell
profile was determined as well as the number of internal vesicles that
they contained.
Results
Y334 is the major phosphorylated tyrosine residue of
Hrs in response to EGF-stimulation
In order to identify tyrosine residues that are phosphorylated
in response to EGF stimulation, Hrs was immunoprecipitated
from HeLa cell lysates derived from cells that had been treated
with or without EGF for 8 minutes (Urbé et al., 2000). After
SDS-PAGE the Hrs band was excised and trypsin-digested in
preparation for MALDI-TOF analysis as described in Materials
and methods. Peptides corresponding to 26% of the human Hrs
sequence could be identified by peptide mass fingerprinting. A
peptide corresponding to amino acids 329-338 plus phosphate
was detected in the EGF-treated sample (Table 1) and was
observed to loose a characteristic mass of 80 Da on post source
decay, indicative of phosphorylation. Two tyrosines (Y329,
Y334) lie within this sequence, but the mass of the peptide
suggests a single phosphorylation indicating that both sites are
not simultaneously phosphorylated. Furthermore this peptide
is unlikely to be generated if Y329 was phosphorylated, as
trypsin cleavage occurs with reduced efficiency when arginine
neighbours a phospho-amino acid. We can therefore conclude
that Y334 is phosphorylated in response to EGF, but cannot
exclude phosphorylation at Y329.
We generated a polyclonal antibody against an Hrs peptide
containing phospho-Y334 to obtain antibodies specific to
phosphorylated Hrs. Fig. 1A shows that the resultant antibody
specifically recognises a band at the appropriate molecular
mass only upon EGF stimulation leading to Hrs
phosphorylation. This result was confirmed with a second
antibody generated against the same peptide isolated from a
different rabbit (data not shown). 
Table 1. MALDI-TOF analysis of tryptic peptides derived from immunoprecipitated Hrs
Expected mass Observed mass 
Peptide sequence Amino acids (Da) (Da) Phosphate EGF-treatment
YLNRNYWEK 329-337 1284.63 1284.57 0 No
NYWEKKQEEAR 333-343 1480.65 1480.65 0 No
YLNRNYWEK 329-337 1364.59 1364.56 +1 Yes
YLNRNYWEKK 329-338 1492.38 1492.39 +1 Yes
Hrs was immunoprecipitated from either non-stimulated or EGF-stimulated cells (8 minutes, 100 ng/ml) and proteins were separated by SDS-PAGE, extracted
from gel pieces and digested with trypsin as described in Materials and methods. The peptide digests were analysed by MALDI-TOF and peptides corresponding
to 26% of human Hrs sequence could be identified in both EGF-treated and untreated samples. Note that the pattern of trypsin cleavage is altered for the
phosphorylated protein: for example peptide 329-338 is only seen in the EGF-treated sample. 
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The UIM-domain of Hrs is required for tyrosine
phosphorylation downstream of EGFR
We made a deletion mutant (ΔUIM) and a double point mutant
(L269A/S270A, LSAA) of the UIM domain as well as Y329F
and Y334F mutants of GFP-Hrs and the corresponding double
tyrosine mutant Y329/334F and expressed them in HeLa cells.
Following EGF stimulation, each of the single tyrosine to
phenylalanine mutants was phosphorylated with a similar
efficiency to wild type as determined by blotting with PY20
antibody. However, phosphorylation of the double mutant was
dramatically reduced (Fig. 1B) although some residual signal
was evident at long exposures of the PY20 blot. Taken together
these results suggest that in the absence of Y334, Y329 can
serve as a phosphorylation site whilst phosphorylation at both
sites simultaneously is unlikely to contribute substantially to
the phospho-tyrosine signal observed. Deletion of the UIM
domain, which lies 50 amino acids upstream of Y329, or
mutation to alanine of L269 and S270 within this domain,
ablated phosphorylation at both sites.
These mutant constructs also provided an additional control
for our phospho-specific Hrs antibody. As expected, neither the
Y334F point mutant nor the double point mutant protein were
recognised by our antibody, in contrast to the Y329F mutant,
which was as efficiently detected as the wild-type protein (Fig.
1C). 
We next tested the specific activity of phospho-Y334 in
membrane and cytosol fractions using our antibody (Fig. 1D).
Previously, we have used immunoprecipitation of Hrs with a
polyclonal antibody [raised against recombinant Hrs (Komada
and Kitamura, 1995)] followed by PY20 blotting and observed
a higher specific activity of phospho-Hrs in the cytosolic
fraction indicative of translocation from membrane to cytosol
(Urbé et al., 2000). We have now repeated these experiments
with a polyclonal anti-peptide antibody (Sachse et al., 2002) and
confirmed our results (data not shown). The availability of a
specific anti-phospho-Hrs antibody allows us to directly probe
for the relative amounts of total Hrs and phospho-Y334-Hrs
in membrane and cytosol fractions without the need of
immunoprecipitation. As shown in Fig. 1D, when equal
proportions of membrane and cytosol fractions are analysed in
parallel, the majority of phospho-Hrs is clearly found in the
cytosol in agreement with our previous findings. When instead
the loading of membrane and cytosolic proteins is roughly
normalised to Hrs levels by comparing four parts of membranes
to one part of cytosol, only a modest enrichment of phospho-
Y334-Hrs-specific activity in the cytosol is evident (Fig. 1E).
Differences in enrichment profiles associated with alternative
experimental approaches may reflect the distribution of extra
phosphorylation sites (e.g. Y329) recognised by the PY20
antibody, or the efficiency of immunoprecipitation of phospho-
Hrs from cytosolic and particulate pools.
Association of Hrs with ubiquitinated proteins is
independent of tyrosine-phosphorylation but requires an
intact UIM-domain
Immunoprecipitation of GFP-tagged Hrs as well as GFP-
Journal of Cell Science 116 (20)
Fig. 1. Tyrosine phosphorylation of
Hrs in response to EGF. (A) An
antibody directed against an Hrs
peptide containing phospho-Y334
recognizes Hrs specifically in response
to EGF stimulation. HeLa cells were
starved for 16 hours in serum-free
medium and either not stimulated or
stimulated for 8 minutes with EGF
(100 ng/ml). Lysates were analysed by
immunoblotting with anti-PY334-Hrs
antibody. Molecular mass markers are
indicated. (B,C) EGF-dependent
tyrosine phosphorylation of Hrs is
dependent on the presence of either
Y329 or Y334 as well as on an intact
UIM domain. (B) HeLa cells were
transfected with GFP-Hrs, GFP-
Y329F, GFP-Y334F, GFP-Y329/334F,
GFP-ΔUIM, GFP-LSAA or mock-
transfected, starved 16 hours in serum-
free medium and then stimulated 22
hours post-transfection with EGF (100
ng/ml). Lysates were prepared and
subjected for immunoprecipitation
with anti-GFP antibody.
Phosphorylation was assessed by immunoblotting with PY20 antibody. (C) Lysates were prepared as described in b and analysed by
immunoblotting with anti-GFP and anti-PY334-Hrs antibodies respectively. The arrowhead indicates GFP-PY334-Hrs, the arrow indicates
endogenous PY334-Hrs. (D) PY334-Hrs is enriched in the cytosol. HeLa cells were starved for 16 hours in serum-free medium and stimulated
for 8 minutes with EGF (100 ng/ml) or left unstimulated. Membrane and cytosol fractions were prepared as described in the Materials and
Methods. The relative distribution of tyrosine phosphorylated Hrs was assessed by analysing equal proportions of membrane and cytosolic
fractions by immunoblotting with anti-Hrs and anti-PY334-Hrs antibodies. (E) Membrane and cytosol fractions were prepared from cells
stimulated for 8 minutes with EGF, and the specific enrichment of Hrs phosphorylated at Y334 was analysed by loading four times more
membrane fraction than cytosol fraction on SDS-PAGE followed by immunoblotting with anti-Hrs and anti-PY334-Hrs antibodies as in D.
4173Hrs-UIM domain in lumenal vesicle formation
Y329/334F from transfected cell lysates followed by
immunoblotting with anti-ubiquitin antibodies, revealed the
presence of a large number of ubiquitinated proteins of both
higher and lower molecular mass (Fig. 2A) indicating that
Hrs participates in a network of interactions involving
ubiquitinated proteins which does not require phosphorylation
of Y334 or Y329. In concurrence, EGF stimulation did not
have any significant effect on the level of ubiquitinated proteins
associated with overexpressed GFP-Hrs and GFP-Y329/334F. 
Deletion of the UIM domain resulted in a significant, but by
no means complete, reduction in the ubiquitin signal when
compared to wild-type Hrs. We reasoned that some of the
ubiquitinated proteins might actually be lost during our
experimental procedures as a result of de-ubiquitination
activities in the cell lysates (Mimnaugh et al., 1999), which are
active at low temperatures. Levels of ubiquitinated proteins co-
immunoprecipitating with GFP-Hrs and GFP-Y329/334F were
dramatically enhanced by inclusion of NEM in the lysis buffer
to inhibit these enzymes, suggesting that the majority of the
associating proteins may indeed be de-ubiquitinated during cell
lysis. Significantly, the ubiquitin-signal detected in the GFP-
ΔUIM immunoprecipitates was not affected by the presence of
NEM and was substantially lower in comparison to GFP-Hrs
and GFP-Y329/334F. 
Ubiquitination of Hrs is independent of tyrosine-
phosphorylation
Inclusion of NEM in the lysis buffer to inhibit de-ubiquitination
does not allow clear visualisation of ubiquitinated Hrs due to
the co-immunoprecipitating ubiquitinated proteins. We
therefore next subjected transfected cells to ‘Boiling SDS-lysis’
(see Materials and Methods), which not only inactivates de-
ubiquitinating enzymes but also destroys many (if not all)
protein-protein interactions. Immunoprecipitations from GFP-
Hrs transfected cell lysates prepared in this way, immunoblotted
with anti-ubiquitin antibodies revealed a sharp band that is not
found in mock-transfected cells, which we presume to be mono-
ubiquitinated GFP-tagged Hrs. This band was present in similar
amounts whether the cells were stimulated with EGF or not, and
when comparing wild-type protein with phosphorylation
defective mutants (Y329/Y334F) (Fig. 2B). In addition, we also
noted the presence of a higher molecular mass smear that may
represent poly-ubiquitinated forms of Hrs. Hrs phosphorylation
is therefore not required for ubiquitination. In agreement with
Polo et al. (Polo et al., 2002), we find a marked reduction in the
degree of ubiquitination for both GFP-ΔUIM and GFP-LSAA
mutants, that is most strikingly manifested by the complete
absence of a poly-ubiquitin smear associated with these two
mutants (Fig. 2B). 
Phosphorylation-defective Hrs localises to early
endosomes 
We next used fluorescence microscopy to examine the
distribution of the mutant and wild-type proteins and establish
their effect on EGFR degradation (Figs 3, 4 and 5). Over-
expression of wild-type protein leads to enlarged clusters of
endosomes, which retain EGFR and prevent its degradation
(Komada and Soriano, 1999; Urbé et al., 2000). All three
transfected proteins (Hrs, Y329/334F and ΔUIM) colocalised to
a large degree with transferrin receptor (Fig. 3A-C) and EEA1
(not shown). However, the ΔUIM mutant failed to form large
Hrs-containing perinuclear endosomal clusters that are
characteristic of wild-type Hrs overexpression: fluorescent
punctae were smaller and more widely dispersed throughout the
cell (Fig. 3C,F). In contrast, in cells overexpressing the
Y329/334F mutant these large structures were accentuated and
more frequently observed even at lower expression levels (Fig.
3B,E). The cation-independent mannose 6-phosphate receptor
(M6PR), becomes entrapped in these large endosomal
structures in cells expressing wild-type and Y329/334F Hrs,
presumably because its trafficking itinerary through the
endosomal pathway is inhibited (Fig. 3D,E). Accumulation of
M6PR in Hrs positive compartments was not apparent with the
ΔUIM mutant (Fig. 3F). None of the constructs colocalised with
Lamp1 or had any effect on its distribution (data not shown). 
Neither tyrosine phosphorylation, nor an intact UIM
domain is necessary for colocalisation of Hrs with the
EGFR in early endosomes
Illustrated in Fig. 4 are cells expressing low amounts of over-
Fig. 2. Ubiquitination of overexpressed Hrs is constitutive and
independent of tyrosine phosphorylation. (A) HeLa cells were
transfected with GFP-Hrs, GFP-Y329F, GFP-Y334F, GFP-
Y329/334F or GFP-ΔUIM, starved for 16 hours in serum-free
medium and then stimulated 22 hours post-transfection for 8 minutes
with EGF (100 ng/ml) or left unstimulated. Lysates were prepared in
the presence or absence of 10 mM NEM and subjected to
immunoprecipitation with anti-GFP antibody. Ubiquitination was
assessed by immunoblotting with anti-ubiquitin antibody. Molecular
mass markers are indicated on the left. (B) HeLa cells were
transfected with GFP-Hrs, GFP-Y329F, GFP-Y334F, GFP-
Y329/334F, GFP-LSAA, GFP-ΔUIM or mock transfected, and
treated as in A. Lysates were prepared according to the ‘boiling SDS-
lysis’ method (see Materials and Methods) and subjected to
immunoprecipitation with anti-GFP antibody. 
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expressed protein, with minimal effect on endosomal
morphology, which have been treated for 8 minutes with EGF.
All three proteins can be seen to decorate endosomal
compartments accessible to EGFR. The failure of the ΔUIM
mutant to undergo EGF-dependent phosphorylation cannot
therefore reflect a lack of coincident localisation between
receptor and Hrs. 
EGFR degradation is blocked by over-expression of wild-
type and Y329/334F Hrs (Fig. 5). Note the intensity of EGFR
in transfected cells compared to neighbouring untransfected
cells (essentially at background levels) all treated for 4 hours
with EGF. In the case of the ΔUIM mutant this effect is much
less pronounced. A typical picture is seen in Fig. 5G-I wherein
a significant fraction of cells expressing GFP-ΔUIM exhibit
close to background levels of EGFR, whilst in other
neighbouring cells EGFR can still be detected in dispersed Hrs-
ΔUIM-positive punctae.
The UIM-domain of Hrs is required for efficient retention
of the EGFR and Hrs at the limiting membrane of the
early endosome
Next, we examined the distribution of the mutant proteins by
immunoelectron microscopy (Fig. 6). As previously reported,
over-expression of Hrs results in increased recruitment of the
clathrin coat to vacuolar endosomes, such that many profiles
are completely covered with clathrin (Raiborg et al.,
2001). For this reason, relative enrichment of markers
in coated regions cannot be quantified under conditions
of over-expression. It is noteworthy that the coat
recruited as a result of Hrs over-expression does not
have the characteristic ‘bilayered’ appearance as in
control cells. Over-expression of Hrs reduces the
number of lumenal vesicles and the proportion of
EGFR labelling (post-stimulation) associated with
these vesicles (Fig. 7 and Table 2). 77±8.2% of EGFR
is retained at the limiting membrane of endosomes
when Hrs is over-expressed, compared with 16±5.6%
in control cells. In addition, the number of lumenal
vesicles in EGFR-positive endosomal vacuoles
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Fig. 3. Immunolocalisation of GFP-Hrs, GFP-Y329/334F and GFP-
ΔUIM. HeLa cells were transfected with GFP-Hrs (A,D), GFP-
Y329/334F (B,E) or GFP-ΔUIM (C,F) and fixed 22 hrs post-
transfection with 3% PFA, permeabilised with Triton X-100 and
stained with either anti-transferrin receptor (TrfR, A-C, shown in
red) or anti-mannose-6-phosphate receptor (Man6PR, D-F, shown in
red) antibodies followed by secondary antibodies coupled to Alexa
Fuor 594. All panels show a single confocal section of a group of
cells presenting the most typical staining pattern for each construct.
Insets show a threefold enlargement of selected areas. Scale bars:
20 µm.
Fig. 4. Colocalisation of Hrs with activated EGFR does not
depend on tyrosine phosphorylation of Hrs or on an intact
UIM domain. HeLa cells were transfected with GFP-Hrs
(A-C), GFP-Y329/334F (D-F) or GFP-ΔUIM (G-I), starved
16 hours in serum-free medium and stimulated 22 hours
post-transfection for 8 minutes with EGF (100 ng/ml). The
cells were then fixed with 3% PFA, permeabilised with
Triton X-100 and stained with anti-EGFR (EGFR shown in
red) followed by secondary antibody coupled to Alexa Fluor
594. All panels show a single confocal section of low-
expressing cells. Insets show a threefold enlargement of
selected areas. Scale bars: 10 µm.
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decreases following Hrs over-expression (Table 2). The
Y329/334F mutant accentuates this sorting defect: 90±3.5% of
EGFR is at the limiting membrane although the number of
internal vesicles is unchanged (Table 2). In contrast, the ΔUIM
mutant (and the UIM-point mutant GFP-LSAA, data not
shown) completely fails to suppress internal vesicle formation
and allows significantly more EGFR to associate with lumenal
vesicles, albeit less efficiently than in control cells. 57±2.2%
of EGFR is at the limiting membrane in these cells. In cells
overexpressing the ΔUIM mutant, lumenal vesicles also
frequently labelled with anti-GFP antibodies indicating the
presence of Hrs (ΔUIM) (Fig. 6C and Fig. 7D). 
Discussion
Hrs is phosphorylated on Y334 in response to EGF
Hrs was originally identified as a major tyrosine
phosphorylated substrate downstream of the Met receptor. The
function of this phosphorylation is presently unclear and
studies have been hampered by the fact that the target
tyrosines were unknown. Human Hrs contains 30 tyrosines,
29 of which are conserved between mouse, rat and human and
of these, six are in turn conserved in Caenorhabditis elegans
and four in Drosophila melanogaster. We have previously
shown that two of these 30 residues, Y197 and Y216 are not
required for EGF-dependent tyrosine phosphorylation of Hrs
(Urbé et al., 2000). In this study, we have used MALDI-TOF
analysis of tryptic peptides derived from Hrs and have been
able to identify the evolutionary conserved Y334 as the main
tyrosine-phosphorylated residue downstream of EGFR in
agreement with the findings by Steen et al. (Steen et al., 2002).
We did not find any direct proof for a physiologically
significant phosphorylation of Y329, however analysis of
overexpressed mutant proteins lacking either Y334 or
Y329 showed that Y329 can function as substrate in the
absence of Y334 (Fig. 1). Phosphorylation on both
residues simultaneously is unlikely to be a feature of the
major proportion of phosphorylated Hrs, since mutation
of either Y329 or Y334 alone does not substantially
decrease the degree of Hrs phosphorylation compared to
wild-type protein. We cannot rule out that other tyrosines
within the molecule may be phosphorylated to a minor
degree as we could still detect a low amount of signal
with phospho-tyrosine antibodies in the Y329/334F
mutant protein. In this respect, it should be noted that our
MALDI-TOF analysis was limited to tryptic peptides and
therefore did not include the 220 C-terminal amino acids
of Hrs that do not contain a trypsin cleavage site.
Phosphorylation at several sites is also suggested, firstly, by
the fact that we observe multiple bands with our phospho-Hrs
antibody (Fig. 1A,E), and secondly, by the study of Bache et
al., who found three distinct spots whilst analysing Hrs
immunoprecipitates by two-dimensional gel electrophoresis
followed by immunoblotting with anti-phospho-tyrosine
antibodies (Bache et al., 2002).
We have generated a polyclonal antibody directed against a
peptide containing phospho-Y334 that specifically recognizes
Hrs in response to EGF-stimulation thus confirming our
MALDI-TOF analysis. We have used this antibody to confirm
that the majority of tyrosine-phosphorylated Hrs is indeed
found in the cytosol as we have previously described (Urbé et
al., 2000). This observation suggests a scenario wherein Hrs
first localises to the early endosome where the
phosphorylation event takes place (Urbé et al., 2000) and
Fig. 5. EGFR downregulation is inhibited by over-expression of
Hrs independently of tyrosine phosphorylation. HeLa cells
were transfected with GFP-Hrs (A-C), GFP-Y329/334F (D-F)
or GFP-ΔUIM (G-I), starved for 16 hours in serum-free
medium and treated 22 hrs post-transfection for 4 hours with
EGF (100 ng/ml). The cells were then fixed with 3% PFA,
permeabilised with Triton X-100 and stained with anti-EGFR
(EGFR shown in red) followed by secondary antibody coupled
to Alexa Fuor 594. All panels show a single confocal section of
cells presenting the most typical staining pattern for each
construct. Scale bars: 20 µm.
Table 2. Effect of wild-type and mutant Hrs over-
expression on EGFR retention
Distribution of EGFR over 
the endosomal vacuole (%) Number of
Limiting Internal Total Number of internal vesicles
membrane vesicles number vacuoles per vacuole
Control 16±5.6 84±5.6 161 74 7±1.3
Hrs 77±8.2 23±8.2 401 159 3±1.1
Hrs-Y329/334F 90±3.5 10±3.5 291 141 3±0.3
Hrs-ΔUIM 57±2.2 43±2.2 294 107 10±3.0
The relative distribution of EGFR over endosomal vacuoles was
determined by counting gold particles (total number indicated) for each
transfection of at least 3×10 cell profiles (see Materials and Methods) and
expressed as percentage of the total label present on vacuoles. For each
EGFR-positive vacuole, the number of internal vesicles was counted. All
values are mean±standard deviation.
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second dissociates from the membrane in response to
phosphorylation. The molecular basis for this dissociation is
intriguing and may result from the disruption of any number
of Hrs interactions: the availability of a phospho-specific Hrs
antibody will now allow us to address this question directly in
future studies.
Phosphorylation of Y334 is not required for
ubiquitination of Hrs
Ubiquitination of tyrosine kinase receptors is frequently
mediated by the E3 ligase c-Cbl (reviewed by Thien and
Langdon, 2001). c-Cbl contains both a RING finger domain,
characteristic of many E3-ligases and a PTB domain, which
recognises phosphorylated receptor and provides for the stable
association of the ubiquitination machinery that may be
necessary for poly-ubiquitination to occur. Tyrosine
phosphorylation on Y334 is clearly not a prerequisite for
ubiquitination of overexpressed Hrs, since the non-
phosphorylated GFP-Y329/334F mutant is ubiquitinated to
the same degree as wild-type GFP-Hrs (Fig. 2B). Hence,
phosphorylated Y334 does not seem to provide a docking
site for the E3 ligase mediating UIM-dependent mono-
ubiquitination of Hrs. In contrast to Polo et al. (Polo et al.,
2002), we did not find any evidence for EGF-dependence of
Hrs ubiquitination and we observed an additional ubiquitin
smear characteristic of poly-ubiquitination, associated with
both wild-type Hrs and phosphorylation-defective Y329/334F
but not with the UIM deletion. This poly-ubiquitinated form of
Hrs was also observed by Katz et al., in a stimulation-
independent manner, in agreement with our study (Katz et al.,
2002). Interestingly, the authors identified the HECT-family
member Nedd4 as the Ubiquitin ligase that may be responsible
for Hrs-ubiquitination in their study. One potential mechanism
of recruitment of HECT-ligases involves a short PY motif
(xPPxY) (Staub et al., 1996) that is indeed present in Hrs
(234PPEY237) and may provide the docking site for Nedd4. 
The UIM domain of Hrs is necessary for tyrosine
phosphorylation
Whilst tyrosine phosphorylation is not required for
ubiquitination, the UIM domain is necessary for efficient
tyrosine phosphorylation of Hrs in response to EGF
stimulation. We do not believe this reflects a requirement for
mono-ubiquitination of Hrs (Polo et al., 2002) since Hrs-
ubiquitination is independent of EGF stimulation in our hands.
Our immunofluorescence studies show that the lack of tyrosine
phosphorylation of the UIM-deletion mutant cannot be
explained simply by mislocalisation: GFP-ΔUIM colocalises
well with early endocytic markers and internalised EGFR.
Failure of phosphorylation must therefore reflect failure of
UIM-dependent molecular associations at the endosomal
surface. This most likely reflects impaired association with
ubiquitinated EGFR but could also be due to a more general
impairment of interactions with ubiquitinated proteins at
endosomes.
Formation of endosomal aggregates requires an intact
UIM-domain
At the level of the light microscope, the morphology and
distribution of the early endosomes in cells overexpressing
GFP-ΔUIM (and GFP-LSAA, data not shown) is clearly
different from that in cells overexpressing GFP-Hrs: the
endosomal vacuoles do not form large clusters in the
perinuclear area but rather remain distributed throughout
the cell. This is not related to the fact that this mutant is
not phosphorylated since the phosphorylation-defective
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Fig. 6. Hrs-Y329/334F and Hrs-ΔUIM are present in clathrin coats
on endosomes. HeLa cells were transfected with GFP-Hrs, GFP-
Y329/334F or GFP-ΔUIM, processed for immunogold-labelling on
cryosections as described in Materials and Methods. Cryosections
were double labeled for GFP (10 nm gold) and clathrin (15 nm gold).
(A-C) Overexpression of GFP-Hrs, GFP-Y329/334F and GFP-ΔUIM
leads to an increased recruitment of clathrin to endosomal vacuoles
(E). All three constructs colocalise with clathrin on the peripheral
endosomal membrane but label is absent from tubular extensions that
emerge from the vacuole (arrows in B and not shown). (C) In
contrast to A and B, cells transfected with GFP-ΔUIM show GFP
labelling at the limiting membrane as well as on internal vesicles of
endosomal vacuoles. PM, plasma membrane. Scale bars: 200 nm.
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Y329/334F mutant forms clusters to an even greater extent than
the wild-type protein. Bishop et al., noted enhanced binding of
an anti-ubiquitin antibody to endosomes following Hrs over-
expression (Bishop et al., 2002). It is conceivable that the
clustering seen with the constructs containing a UIM-domain
may result from the accumulation of poly-ubiquitinated
proteins in the limiting endosomal membrane and the
crosslinking of these endosomal vacuoles through
ubiquitin:Hrs-UIM interactions. 
The dominant-negative effect of Hrs overexpression on
internal vesicle formation requires an intact UIM domain
Over-expression of wild-type Hrs inhibits the downregulation
of EGFR, illustrated here by the persistence of EGFR staining
in the early endosome after 4 hours of continuous stimulation
with EGF. This dominant negative effect of Hrs over-
expression may be due to titration of interacting factors that
become limiting and are required downstream of Hrs for EGFR
sorting and degradation [e.g. STAM/Hbp, Tsg101 (Babst et al.,
2000; Bishop et al., 2002; Takata et al., 2000)] or for the release
of Hrs from endosomal membranes. We have previously
shown that only a small percentage of overexpressed Hrs is
phosphorylated (Urbé et al., 2000). Since phosphorylation of
Hrs may act as a trigger for membrane dissociation, it is not
surprising that the phosphorylation-defective Y329/334F
mutant recapitulates the dominant negative phenotype of the
wild-type protein. The UIM-deletion mutant in contrast had a
much less pronounced effect on EGFR downregulation. 
Quantitative analysis by electron microscopy of EGFR
sorting at the early endosome provides high-resolution support
for this assessment. Expression of wild-type Hrs, as well as of
both mutated forms of Hrs (Y329/334F and ΔUIM), led to the
recruitment of a clathrin-based coat to the early endosome that
lacks the characteristic striations seen in the
Hrs/clathrin coat of non-transfected cells (Sachse et
al., 2002). However, the UIM deletion mutant differs
from the other two constructs in three important
ways: (i) whilst wild-type Hrs, as well as the
phosphorylation defective Y329/334F mutant causes
a dramatic retention of EGFR in the limiting membrane
compared to mock-transfected cells, this effect is suppressed
by deletion of the UIM motif; (ii) whereas the wild-type GFP-
Hrs and the Y329/334F mutant, just like the endogenous
protein, are completely retained at the limiting membrane of
the early endosome, the UIM-deletion mutant seems to escape
that retention mechanism along with the EGFR and appears in
the lumenal vesicles (Fig. 6C, Fig. 7D) and (iii) concomitantly
with the retention of the EGFR, both wild-type Hrs and
Y329/334F over-expression lead to a reduction in the observed
number of internal vesicles whereas the UIM-deletion mutant
appears without effect, in agreement with studies in yeast
showing that deletion of the UIM domain of Vps27 does not
impinge on the formation of lumenal vesicles (Bilodeau et al.,
2002). In summary, deletion of the UIM domain suppresses the
inhibitory effect of Hrs over-expression on lumenal vesicle
formation and consequent internalisation of EGFR from the
limiting membrane. 
A role for the UIM-domain of Hrs in the co-ordination of
receptor sorting and vesicle formation
We propose that the initial role of the UIM domain of Hrs at
the sorting endosome is to recruit ubiquitinated receptors into
the clathrin-coated microdomains by an active retention
mechanism as a prelude to internalisation into lumenal
vesicles. There must, however, be a release mechanism prior
to incorporation of EGFR into inward budding vesicles, as Hrs
and other coat components are normally not internalised. It is
tempting to speculate that Hrs, or more precisely, the UIM
domain of Hrs has to be displaced from the ubiquitinated
receptor complex for internal vesicle formation to occur.
Displacement of the Hrs-UIM by a competing Ubiquitin-
binding protein, possibly a component of the downstream
Fig. 7. The UIM domain of Hrs is required for efficient
retention of the EGFR at the limiting membrane of the
early endosome. HeLa cells were transfected with GFP-Hrs
(B), GFP-Y329/334F (C) or GFP-ΔUIM (D), or mock-
transfected (A), starved 16 hours in serum-free medium
and stimulated 22 hrs post-transfection for 30 minutes with
EGF. Cells were processed for immunogold-labelling on
cryosections as described in Materials and methods and
cryosections were double-labeled for GFP (10 nm gold)
and EGFR (15 nm gold). (A) In control cells, EGFR is
mainly localized on internal vesicles of endosomal
vacuoles. (B) In cells overexpressing GFP-Hrs, EGFR is
retained in the limiting membrane of endosomal vacuoles
(arrows). (C) In HeLa cells expressing GFP-Hrs
Y329/334F, EGFR is retained at the limiting membrane of
endosomal vacuoles (arrows). (D) By contrast, in cells
transfected with GFP-Hrs-ΔUIM, EGFR is localized at the
limiting membrane (arrows) as well as on internal vesicles
(arrowheads). E, endosomal vacuole; N, nucleus; PM,
plasma membrane. Scale bars: 200 nm.
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acting ESCRT complex [e.g. Tsg101 (Babst et al., 2000;
Bishop et al., 2002; Katzmann et al., 2001)], would then be
able to release the clamp that Hrs imposes by recruiting further
downstream elements of the ESCRT complexes (Babst et al.,
2002a; Babst et al., 2002b), ultimately leading to vesicle
formation. In this way Hrs dissociation from the Ubiquitin-
receptor complex may be directly coupled to vesicle formation:
besides allowing recruitment of the vesicle formation
machinery to the ubiquitinated receptor, dissociation of Hrs
could also serve to release the receptor complex from the
clathrin-coated patch and allow (or facilitate) lateral diffusion
out of this microdomain, which by nature of the rigid clathrin
coat may be unable to invaginate. Indeed, profiles of inward
budding vesicles are not observed underneath the clathrin coat
but immediately adjacent to it (Sachse et al., 2002). 
Based on this model, over-expression of wild type Hrs or
Y329/334F Hrs accentuates the retention of receptors without
effectively coupling to downstream factors mediating vesicle
formation. In contrast, the UIM mutant of Hrs is unable to
execute this clamp action and EGFR incorporation into
vesicles proceeds albeit in a more stochastic and less efficient
manner than in control cells presumably since overexpression
of any endosome-localised, clathrin binding form of Hrs does
not allow for local concentration of receptor complexes in
clathrin-coated patches, which now frequently represent the
entire vacuolar endosomal surface. 
Why then is the UIM mutant of Hrs incorporated into
internal vesicles? It is possible that the association between Hrs
and the receptor complex is not solely mediated by the UIM
domain and complete dissociation of Hrs from the receptor
complex may yet require tyrosine phosphorylation of Hrs. This
in turn, as we show here, requires an intact UIM domain,
presumably to allow Hrs to engage in a network of ubiquitin-
mediated interactions that may also serve to present Hrs to the
relevant kinase.
Until now, high resolution data linking the Hrs UIM domain
with receptor sorting into lumenal vesicles have not been
available, although much has been made of circumstantial
evidence. The domain binds ubiquitin and inhibits plasma
membrane-directed recycling of a transferrin receptor-
ubiquitin hybrid (Raiborg et al., 2002). Our data go beyond this
to show that over-expression of Hrs inhibits formation of
endosome lumenal vesicles that contain endogenous activated
EGFR and that this inhibition requires the UIM domain of Hrs.
This indicates a complex role for Hrs in lumenal vesicle
formation, having both positive and negative aspects that may
represent ‘checkpoint’ control of vesicle formation, ensuring
that under physiological circumstances it is effectively coupled
to cargo loading. 
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